Impact of Polypharmacy on Occurrence of Delirium in Elderly Emergency Patients

Journal of the American Medical Directors Association

Volumn 15, Issue 11, 2014, Pages 850.e11-850.e15

  Hein, Christophe ^a   Forgues, Adrien ^a   Piau, Antoine ^a   Sommet, Agnès ^b,c   Nourhashémi, Fati ^a,c   Vellas, Bruno ^a,c  

^a TOULOUSE UNIVERSITY HOSPITAL   (France)

^b UNIVERSITÉ DE TOULOUSE   (France)

^c INSERM   (France)

Author keywords

Delirium; Drug induced delirium; Elderly; Geriatrics; Polypharmacy

Indexed keywords

BENZAMIDE; BENZAMIDE DERIVATIVE; BENZODIAZEPINE DERIVATIVE; BUTYROPHENONE DERIVATIVE; CIPROFLOXACIN; DOPAMINE RECEPTOR STIMULATING AGENT; HISTAMINE H1 RECEPTOR ANTAGONIST; HYDROXYZINE; HYPNOTIC AGENT; LEVODOPA; LEVOFLOXACIN; LITHIUM; MEPROBAMATE; METHYLPREDNISOLONE; MORPHINE; MOXIFLOXACIN; NEUROLEPTIC AGENT; NORFLOXACIN; OFLOXACIN; OPIATE; PHENOTHIAZINE DERIVATIVE; PREDNISOLONE; PREDNISONE; QUINOLONE DERIVATIVE; THIOXANTHENE DERIVATIVE; TRAMADOL; TRICYCLIC ANTIDEPRESSANT AGENT; UNINDEXED DRUG; ZOLPIDEM; ZOPICLONE;

AGED; ARTICLE; CARDIOVASCULAR DISEASE; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DELIRIUM; DISEASE PREDISPOSITION; FEMALE; FUNCTIONAL STATUS; GERIATRIC DISORDER; GERIATRICIAN; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; NURSING HOME; POLYPHARMACY; PRESCRIPTION; PROSPECTIVE STUDY; STUDY DESIGN; UNIVERSITY HOSPITAL; VERY ELDERLY; CHEMICALLY INDUCED; EMERGENCY HEALTH SERVICE; FRANCE; INTERVIEW; MEDICAL AUDIT;

AGED; AGED, 80 AND OVER; COHORT STUDIES; DELIRIUM; EMERGENCY SERVICE, HOSPITAL; FEMALE; FRANCE; HOSPITALIZATION; HUMANS; INTERVIEWS AS TOPIC; MALE; MEDICAL AUDIT; POLYPHARMACY;

EID: 84908224608     PISSN: 15258610     EISSN: 15389375     Source Type: Journal    
DOI: 10.1016/j.jamda.2014.08.012     Document Type: Article

References (47)

1. Siddiqi N., Horne A.O., House A.O., Holmes J.D. Occurrence and outcome of delirium in medical in-patient: A systematic literature review. Age Ageing 2006, 35:350-364.
2. Young J., Inouye S.K. Delirium in older people. BMJ 2007, 334:842-846.
3. Kiely D.K., Marcantonio E.R., Inouye S.K., et al. Persistent delirium predicts greater mortality. JAm Geriatr Soc 2009, 57:55-61.
4. Elie M., Cole M.G., Primeau F.J., et al. Delirium risk factors in elderly hospitalized patients. JGen Intern Med 1998, 13:204-212.
5. Han J.H., Shintani A., Eden S., et al. Delirium in the emergency department: An independent predictor of death within 6 months. Ann Emerg Med 2010, 56:244-252.
6. Eeles E.M., Hubbard R.E., White S.V., et al. Hospital use, institutionalisation and mortality associated with delirium. Age Ageing 2010, 39:470-475.
7. Witlox J., Eurelings L.S., de Jonghe J.F., et al. Delirium in elderly patients and the risk of postdischarge mortality, institutionalization, and dementia: A meta-analysis. JAMA 2010, 304:443-451.
8. McCusker J., Cole M.G., Dendukuri N., et al. Does delirium increase hospital stay?. JAm Geriatr Soc 2003, 51:1539-1546.
9. Fong T.G., Jones R.N., Shi P., et al. Delirium accelerates cognitive decline in Alzheimer disease. Neurology 2009, 72:1570-1575.
10. Fong T.G., Tulebaev S.R., Inouye S.K. Delirium in elderly adults: Diagnosis, prevention and treatment. Nat Rev Neurol 2009, 5:210-220.
11. Alagiakrishnan K., Wiens C.A. An approach to drug induced delirium in the elderly. Postgrad Med J 2004, 80:388-393.
12. Han L., McCusker J., Cole M., et al. Use of medications with anticholinergic effect predicts clinical severity of delirium symptoms in older medical inpatients. Arch Intern Med 2001, 161:1099-1105.
13. Lin R.Y., Heacok L.C., Fogel J.F. Drug-induced, dementia-associated and nondementia, non-drug delirium hospitalizations in the United States, 1998-2005: An analysis of the national inpatient sample. Drugs Aging 2010, 27:51-61.
14. Inouye S.K., Charpentier P. Precipiting factors for delirium in hospitalised elderly persons. Predictive model and interrelationship with baseline vulnerability. JAMA 1996, 275:852-857.
15. Hanlon J.T., Schmader K.E., Ruby C.M., et al. Suboptimal prescribing in older inpatients and outpatients. JAm Geriatr Soc 2001, 49:200-209.
16. Hajjar E.R., Cafiero A.C., Hanlon J.T. Polypharmacy in elderly patients. Am J Geriatr Pharmacother 2007, 5:345-351.
17. Huisman-Baron M., van der Veen L., Jansen P.A., et al. Criteria for drug selection in frail elderly persons. Drugs Aging 2011, 28:391-402.
18. Rochon P.A., Gurwitz J.H. Drug therapy. Lancet 1995, 346:32-36.
19. Handler S.M., Wright R.M., Ruby C.M., et al. Epidemiology of medication-related adverse events in nursing homes. Am J Geriatr Pharmacother 2006, 4:264-272.
20. Dwyer L.L., Han B., Woodwell D.A., et al. Polypharmacy in nursing home residents in the United States: Results of the 2004 National Nursing Home Survey. Am J Geriatr Pharmacother 2010, 8:63-72.
21. Lindblad C.I., Artz M.B., Pieper C.F., et al. Potential drug-disease interactionsin frail, hospitalized elderly veterans. Ann Pharmacother 2005, 39:412-417.
22. Kohler G.I., Bode-Boger S.M., Busse R., et al. Drug-drug interactions in medical patients: Effects of in-hospital treatment and relation to multiple drug use. Int J Clin Pharmacol Ther 2000, 38:504-513.
23. Astrand E., Astrand B., Antonov K., et al. Potential drug interactions during a three-decade study period: A cross-sectional study of a prescription register. Eur J Clin Pharmacol 2007, 63:851-859.
24. Johnell K., Klarin I. The relationship between number of drugs and potentialdrug-drug interactions in the elderly: A study of over 600,000 elderly patients from the Swedish Prescribed Drug Register. Drug Saf 2007, 30:911-918.
25. Leendertse A.J., Egberts A.C., Stoker L.J., et al. Frequency of and risk factors for preventable medication-related hospital admission in The Netherlands. Arch Intern Med 2008, 168:1890-1896. HARM Study Group.
26. Laroche M.L., Charmes J.P., Nouaille Y., et al. Is inappropriate medication use a major cause of adverse drug reactions in the elderly?. Br J Clin Pharmacol 2007, 63:177-186.
27. Fialová D., Topinkova E., Gambassi G., et al. Potentially inappropriate medication use among elderly home care patients in Europe. JAMA 2005, 293:1348-1358.
28. Wei L.A., Fearing M.A., Sternberg E.J., et al. The Confusion Assessment Method: A systematic review of current usage. JAm Geriatr Soc 2008, 56:823-830.
29. Viktil K.K., Blix H.S., Moger T.A., et al. Polypharmacy as commonly defined is an indicator of limited value in the assessment of drug-related problems. Br J Clin Pharmacol 2007, 63:187-195.
30. Rollason V., Vogt N. Reduction of polypharmacy in the elderly: A systemic review of the role of the pharmacist. Drugs Aging 2003, 20:817-832.
31. Campbell S.E., Seymour D.G., Primrose W.R. Asystematic literature review of factors affecting outcome in older medical patients admitted to hospital. Age Ageing 2004, 33:110-115.
32. Hustey F.M., Meldon S.W., Smith M.D., et al. The effect of mental status screening on the care of elderly emergency department patients. Ann Emerg Med 2003, 41:678-684.
33. Han J.H., Zimmerman E.E., Cutler N., et al. Delirium in older emergency department patients: Recognition, risk factors, and psychomotor subtypes. Acad Emerg Med 2009, 16:193-200.
34. Wong C.L., Holroyd-Leduc J., Simel D.L., et al. Does this patient have delirium? Value of bedside instruments. JAMA 2010, 304:779-786.
35. Carrière I., Fourrier-Reglat A., Dartigues J.F., et al. Drugs with anticholinergic properties, cognitive decline, and dementia in an elderly general population: The 3-city study. Arch Intern Med 2009, 169:1317-1324.
36. Glass J., Lanctôt K.L., Herrmann N., et al. Sedative hypnotics in older people with insomnia: Meta-analysis of risks and benefits. BMJ 2005, 331:1169.
37. Clegg A., Young J.B. Which medications to avoid in people at risk of delirium: A systematic review. Age Ageing 2011, 40:23-29.
38. Stahlmann R., Lode H. Safety considerations of fluoroquinolones in the elderly: An update. Drugs Aging 2010, 27:193-209.
39. Vik S.A., Maxwell C.J., Hogan D.B. Measurement, correlates, and health outcomes of medication adherence among seniors. Ann Pharmacother 2004, 38:303-312.
40. Carbonin P., Pahor M., Bernabei R., et al. Is age an independent risk factor of adverse drug reactions in hospitalized medical patients?. JAm Geriatr Soc 1991, 39:1093-1099.
41. Field T.S., Gurwitz J.H., Avorn J., et al. Risk factors for adverse drug events among nursing home residents. Arch Intern Med 2001, 161:1629-1634.
42. Onder G., Pedone C., Landi F., et al. Adverse drug reactions as cause of hospital admissions: Results from the Italian Group of Pharmacoepidemiology in the Elderly (GIFA). JAm Geriatr Soc 2002, 50:1962-1968.
43. Gellad W.F., Grenard J.L., Marcum Z.A. Asystematic review of barriers to medication adherence in the elderly: Looking beyond cost and regimen complexity. Am J Geriatr Pharmacother 2011, 9:11-23.
44. Cole M.G., You Y., McCusker J., et al. The 6 and 12 month outcomes of older medical inpatients who recover from delirium. Int J Geriatr Psychiatry 2008, 23:301-307.
45. Onder G., Petrovic M., Tangiisuran B., et al. Development and validation of a score to assess risk of adverse drug reactions among in-hospital patients 65 years or older: The GerontoNet ADR risk score. Arch Intern Med 2010, 170:1142-1148.
46. García-Gollarte F., Baleriola-Júlvez J., Ferrero-López I., et al. An educational intervention on drug use in nursing homes improves health outcomes resource utilization and reduces inappropriate drug prescription. JAm Med Dir Assoc 2014, In press.
47. Gizzi L.A., Slain D., Hare J.T., et al. Assessment of a safety enhancement to the hospital medication reconciliation process for elderly patients. Am J Geriatr Pharmacother 2010, 8:127-135.